The EMA still views Protelos/Osseor (strontium ranelate) from Servier Labs as an "important treatment" for women with Osteoporosis and its...
The European Medicines Agency has concluded its review of Protelos/Osseor from Servier and has recommended further restricting the use of...
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended restrictions in the use of Protelos/Osseor (strontium ranelate) from Servier, following the...
European regulators have recommended suspending Protelos (strontium ranelate) from Servier because of the risk of serious heart problems and blood...